Unexpected results of the drug mtformin (glucophage) in the fight against prostate cancer

A study conducted by the modern Canadian group of researchers at the University of Tornoto that the drug "Metformin" helps to reduce and delay the growth of prostate cancer and that when used before resorting to the eradication operations.
And broadcast the results in the annual scientific conference held by the American Association for Cancer Research in Chicago, in the period of the thirty-first of the month of March to the fourth month of April.

The drug metformin more drug used and very common for the treatment of diabetes type II, which mostly affects the elderly, and months, pharmaceutical products that contain it Sidovaj drug.
The study included about 22 men who make sure contracting prostate cancer, and they were attending to take 3 tablets of the drug metformin on a daily basis, each of which contains a concentration of 500 mg for 41 consecutive days, without being subjected to the process of removal of the prostate.
The study indicated that metformin has succeeded in reducing the rate of growth of the prostate gland tumors and slowed the spread of cancer, in addition to that he had succeeded in reducing a vital pathways that contribute to the growth of cancer cells.
States that have emerged recently a number of recent studies that reveal the benefits of additional characteristic of metformin is to reduce the level of blood sugar, most notably noted for his role in protecting the heart from various diseases as well as its role in reducing the incidence of oral cancer in addition to its use in the treatment of polycystic ovaries in women Finally, reduce the rate of body fat.